Line-Up Announced for iSOFT-Sponsored ePMA Excellence Forums

iSOFTSteve Freeborn, a renowned pharmacist and contributor to the landmark report on medication errors, 'A Spoonful of Sugar - Medicines management in NHS hospitals', will be among the speakers at iSOFT-sponsored e-prescribing conferences at Wembley on 20 October and Old Trafford on 10 November.

Freeborn's keynote address, "There and back again - a pharmacist's tale", will describe how pharmacy management in the NHS has witnessed many changes over the years, yet advanced relatively little.

In a recent article, Freeborn said traditionally the NHS lacked the drive to make e-prescribing a reality but the current cost cutting is a game-changer, as it risks patient safety.

"The line-up of distinguished speakers from academia and the NHS promises a lively debate and useful exchange of ideas," said Adrian Stevens, managing director of iSOFT's UK and Ireland business, who is hosting the events.

Both ePMA Excellence Forums are free and open to anyone wanting to learn more about the realities of implementing an e-prescribing and medicines administration (ePMA) system. To reserve a place, click here.

Other speakers and sessions include:

  • Dr Rachel Howard, University of Reading; “People and computers: error producing or defensive?”
  • Prof Tim Dornan, University of Maastricht; “Education and the impact on prescribing behaviours.”

There are also sessions offering some practical advice on implementing ePMA systems in the NHS:

  • Helen Bennett, Stockport NHS Foundation Trust; “Establishing baseline and performance measures.”
  • Alex Jennings, University Hospital Aintree; “ePMA risks and benefits.”
  • Steve Wardell and Bala Sridhar, The Christie Hospital NHS Foundation Trust; “Implementing a complex ePMA solution.”

Related news articles:

About iSOFT, a CSC company
Headquartered in Banbury, UK, iSOFT is one of the world's largest healthcare IT companies serving 13,000 healthcare providers in over 40 countries across five continents. Its software product portfolio is one of the most extensive available, covering every aspect of healthcare delivery and planning. These include interoperable e-health solutions that build on existing systems to maximise current investments.

iSOFT's business is driven by the collective talent, experience and commitment of over 3,000 specialists in 19 countries. Through a global network of subsidiaries and extensive partner network, iSOFT also has substantial experience of national healthcare sectors and expert knowledge of local market needs.

iSOFT is a CSC company.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...